Synthesis and Radiolabeling of Glu-Urea-Lys with <sup>99m</sup>Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor-Reference-Cited by-同舟云学术

Synthesis and Radiolabeling of Glu-Urea-Lys with ^99mTc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor

Published:2023-09-01 Issue:7 Volume:38 Page:486-496
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Hatamabadi Dara¹^ORCID,Joukar Safura²,Shakeri Pegah³,Balalaie Saeed³,Yazdani Abdolreza¹,Khoramjouy Mona⁴,Mazidi Seyed Mohammad⁵,Kobarfard Farzad¹,Mosayebnia Mona¹,Bozorgchami Negar¹,Ahmadi Mahnaz⁶^ORCID,Ayyoubzadeh Seyed Mohammad⁷^ORCID,Shahhosseini Soraya¹⁸^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry and Radiopharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2. Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

3. Peptide Chemistry Research Institute, K. N. Toosi University of Technolology, Tehran, Iran.

4. Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

5. Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran.

6. Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

7. Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.

8. Protein Technology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2023.0024

Reference41 articles.

1. The Value of 99mTc-PSMA SPECT/CT-Guided Surgery for Identifying and Locating Lymph Node Metastasis in Prostate Cancer Patients

2. Prostate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-Choline

3. The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

4. Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers